Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

PTLA

Portola Pharmaceuticals (PTLA)

Portola Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PTLA
DateHeureSourceTitreSymboleSociété
21/01/202021h51Business WireShareholder Alert: Robbins LLP Announces Portola Pharmaceuticals, Inc. (PTLA) Sued for Misleading ShareholdersNASDAQ:PTLAPortola Pharmaceuticals Inc
18/01/202001h17Business WirePTLA LOSSES ALERT: Bernstein Liebhard LLP Announces the Filing of a Securities Class Action Against Portola Pharmaceuticals, ...NASDAQ:PTLAPortola Pharmaceuticals Inc
17/01/202022h01Business WireThe Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Portola Pharmaceuticals, Inc....NASDAQ:PTLAPortola Pharmaceuticals Inc
11/01/202000h41Business WireThe Law Offices of Frank R. Cruz Announces Investigation on Behalf of Portola Pharmaceuticals, Inc., (PTLA)NASDAQ:PTLAPortola Pharmaceuticals Inc
10/01/202018h04PR Newswire (US)(PTLA) Alert: Johnson Fistel Launches Investigation into Portola Pharmaceuticals; Investors Encouraged to Contact FirmNASDAQ:PTLAPortola Pharmaceuticals Inc
09/01/202022h20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTLAPortola Pharmaceuticals Inc
09/01/202022h01PR Newswire (US)Portola Announces Preliminary Full Year 2019 Andexxa Global Net Revenues of Approximately $111 MillionNASDAQ:PTLAPortola Pharmaceuticals Inc
08/01/202020h03Edgar (US Regulatory)Schedule 13gNASDAQ:PTLAPortola Pharmaceuticals Inc
23/12/201914h30PR Newswire (US)Portola Pharmaceuticals to Webcast Corporate Update on January 14, 2020NASDAQ:PTLAPortola Pharmaceuticals Inc
17/12/201914h30PR Newswire (US)Portola Pharmaceuticals to Support New American Heart Association Initiative to Address Hemorrhagic StrokeNASDAQ:PTLAPortola Pharmaceuticals Inc
09/12/201921h21PR Newswire (US)Portola Pharmaceuticals Presents New Interim Data at the 61st ASH Meeting on its Oral SYK/JAK Inhibitor Cerdulatinib in Heavi...NASDAQ:PTLAPortola Pharmaceuticals Inc
08/12/201918h00PR Newswire (US)Portola Pharmaceuticals Presents New Interim Data from Ongoing Phase 2a Study of its Oral SYK/JAK Inhibitor Cerdulatinib in H...NASDAQ:PTLAPortola Pharmaceuticals Inc
15/11/201922h25PR Newswire (US)Andexxa Highlighted as a First-Line Factor Xa Reversal Option by the American College of Emergency PhysiciansNASDAQ:PTLAPortola Pharmaceuticals Inc
06/11/201916h07PR Newswire (US)Portola Pharmaceuticals to Present Multiple Abstracts at the 61st American Society of Hematology (ASH) Annual MeetingNASDAQ:PTLAPortola Pharmaceuticals Inc
05/11/201923h12Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTLAPortola Pharmaceuticals Inc
05/11/201922h00PR Newswire (US)Portola Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:PTLAPortola Pharmaceuticals Inc
01/11/201921h30PR Newswire (US)Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:PTLAPortola Pharmaceuticals Inc
28/10/201914h00PR Newswire (US)Portola Pharmaceuticals Presents New Analysis from the ANNEXA-4 Study of its Factor Xa Inhibitor Reversal Agent Andexxa® in ...NASDAQ:PTLAPortola Pharmaceuticals Inc
15/10/201914h30PR Newswire (US)Portola Pharmaceuticals to Announce Third Quarter 2019 Financial Results on Tuesday, November 5, 2019NASDAQ:PTLAPortola Pharmaceuticals Inc
02/10/201922h21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTLAPortola Pharmaceuticals Inc
02/10/201922h17Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PTLAPortola Pharmaceuticals Inc
19/09/201914h20PR Newswire (US)Portola Pharmaceuticals Appoints Ted W. Love, M.D., to its Board of DirectorsNASDAQ:PTLAPortola Pharmaceuticals Inc
22/08/201914h30PR Newswire (US)Portola Pharmaceuticals to Participate in Two Upcoming Investor ConferencesNASDAQ:PTLAPortola Pharmaceuticals Inc
14/08/201922h15Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PTLAPortola Pharmaceuticals Inc
14/08/201901h32PR Newswire (US)Portola Pharmaceuticals Announces Pricing of Public Offering of Common StockNASDAQ:PTLAPortola Pharmaceuticals Inc
12/08/201922h43PR Newswire (US)Portola Pharmaceuticals Announces Proposed Offering of Common StockNASDAQ:PTLAPortola Pharmaceuticals Inc
07/08/201923h16Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PTLAPortola Pharmaceuticals Inc
07/08/201923h12Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:PTLAPortola Pharmaceuticals Inc
07/08/201922h05PR Newswire (US)Portola Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:PTLAPortola Pharmaceuticals Inc
06/08/201914h30PR Newswire (US)Portola Launches European Sales of Ondexxya® (Andexanet Alfa) with First Orders in EuropeNASDAQ:PTLAPortola Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PTLA

Dernières Valeurs Consultées

Delayed Upgrade Clock